破骨细胞形成抑制因子(OPG/OCIF)是最近发现的一种参与调节骨密度的糖蛋白,是一个肿瘤坏死因子(TNF)受体超家族的新成员,其氨基酸序列中具有TNF受体结构类似区.成熟的OPG/OCIF具有7个结构域,可分为三个功能区,即:TNF受体结构区、致死结构区和肝素结合区.OPG/OCIF基因定位在8q23~24上,由5个外显子和4个内含子组成,其表达受到与骨的形成和破坏有关因子的调控:如TGF-β1、1,25(OH)2VD3、TNF-α等等.OPG/OCIF抑制骨的破坏和吸收机制主要是抑制破骨细胞的存活,引起破骨细胞凋亡和抑制破骨细胞形成.
Osteoclastogenesis inhibitory factor or osteoprotegerin(OPG/OCIF) is a novel secreted glycoprotein involved in the regulation of bone density. It is a novel member of the TNF receptor superfamily. Mature OPG/OCIF contains 7 domains and can be divided into 3 regions(TNF receptor cysteine-rich region; death domain region and heperin binding region). The OPG/OCIF gene is a single-copy gene consisting of five exons and four introns. It is located in 8q23~24. The factors involved in the regulation of bone formation and resoption(eg. TGF-β1,1,25(OH)2VD3 and TNF-α)regulate the expression of OPG/OCIF gene. The mechanisms by which OPG/OCIF inhibits bone resoption can be concluded that: 1) OPG/OCIF inhibits survival of osteoclasts and induces apoptosis of osteoclasts; 2) OPG/OCIF inhibits formation of osteoclasts.
何志勇,李明峰,张惟杰,吴祥甫.破骨细胞形成抑制因子研究进展[J].生物化学与生物物理进展,2000,27(5):469-472
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号